$4.26
+6.2%SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
Strong gross margins indicate healthy pricing and efficient production or service delivery.
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
SSII • NASDAQ
| SS Innovations International, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||
42.4M | 20.6M | 5.9M | 1.5M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
GROSS PROFIT | ||||||||||
(24M) | (12.2M) | (5.2M) | (968.7K) | (18.8K) | (37.4K) | (37.7K) | (19.5K) | (789.0) | (0.0) | |
18.4M | 8.5M | 713.4K | 489.6K | -18.8K | -37.4K | -37.7K | -19.5K | -789.0 | 0.0 | |
OPERATING INCOME | ||||||||||
(26.5M) | (27.4M) | (21.4M) | (6.2M) | (1.4M) | (1.1M) | (3.3M) | (940.9K) | (1M) | (462.5K) | |
(22.9M) | (24.5M) | (20.8M) | (6.1M) | (1.4M) | (1.1M) | (3.2M) | (913.8K) | (938.8K) | (324.1K) | |
(3.7M) | (2.5M) | (576.2K) | (83.3K) | (1K) | (3K) | (60.9K) | (27.1K) | (71.2K) | (138.4K) | |
-8.2M | -19M | -20.7M | -5.7M | -1.4M | -1.1M | -3.3M | -960.4K | -1M | -462.5K | |
PRE-TAX INCOME | ||||||||||
(1.1M) | (973.2K) | (523.4K) | (162K) | (0.0) | (1.1K) | (0.0) | (0.0) | (27K) | (22.5K) | |
-1.1M | -175.2K | -393.6K | 77.7K | 118.0 | -1.1K | 0.0 | 0.0 | -26.9K | -22.5K | |
(0.0) | (436K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-9.8K | -175.2K | -273.6K | 77.7K | -77.3K | -21.8K | -63.3K | 58.0 | -26.9K | -22.5K | |
-8.2M | -19.2M | -20.9M | -5.6M | -1.5M | -1.1M | -3.4M | -960.3K | -1M | -485K | |
NET INCOME | ||||||||||
(4M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -3.0 | (2.0) | (0.0) | |
-12.1M | -19.2M | -20.9M | -5.6M | -1.5M | -1.1M | -3.4M | -960.3K | -1M | -485K |
SSII - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 26, 2026 | May 18, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 13, 2026 | May 13, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 13, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
S-3 S-3 N/A | May 01, 2026 | May 01, 2026 | ||
8-K 8-K 2026 N/A | April 23, 2026 | April 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 07, 2026 | April 07, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | March 31, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 30, 2026 | 2026 |
Continue your SSII research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.